{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:25:42Z","timestamp":1757615142821,"version":"3.44.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Left atrial appendage occlusion (LAAO) is an alternative to oral anticoagulation for stroke prevention in atrial fibrillation (AF), especially in patients at high bleeding risk. While generally safe, LAAO involves procedural and postprocedural risks. The most serious complication is pericardial effusion or tamponade; other periprocedural risks include stroke, device embolization, vascular injury, major bleeding, and air embolism. With improved techniques, serious complication rates have declined to under 2%. Ideal candidates for LAAO are patients with nonvalvular AF and elevated CHA\u2082DS\u2082-VASc scores who are poor oral anticoagulation candidates due to high HAS-BLED scores or contraindications. Major trials have shown LAAO to be noninferior to warfarin or direct oral anticoagulants in preventing stroke and systemic embolism. A clear understanding of patient selection, procedural safety, and long-term risks is critical to optimizing LAAO outcomes and expanding its role in AF management. This review aimed to discuss the current evidence, indications, outcomes, evidence gaps, and future directions of LAAO devices.<\/jats:p>","DOI":"10.1097\/crd.0000000000001035","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T13:01:18Z","timestamp":1757077278000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Left Atrial Appendage Occlusion Devices Focused on Complications of Therapy"],"prefix":"10.1097","author":[{"given":"Cristian","family":"Castillo-Rodriguez","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Salguero","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Texas Tech University Health Sciences Center, El Paso, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Cruz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Soliman","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firas","family":"Ashour","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Ridha","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care, Texas Tech University Health Sciences Center, El Paso, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amro","family":"Aglan","sequence":"additional","affiliation":[{"name":"Departments of Cardiology and Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haris","family":"Patail","sequence":"additional","affiliation":[{"name":"Departments of Cardiology and Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[{"name":"Department of Medicine, New York Medical College, Valhalla, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilbert S.","family":"Aronow","sequence":"additional","affiliation":[{"name":"Departments of Cardiology and Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"key":"R1-20250905","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"R2-20250905","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials.","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R3-20250905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R4-20250905","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation.","volume":"75","author":"Osmancik","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R5-20250905","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"R6-20250905","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial.","volume":"312","author":"Reddy","year":"2014","journal-title":"JAMA"},{"key":"R7-20250905","doi-asserted-by":"crossref","first-page":"e034815","DOI":"10.1161\/JAHA.124.034815","article-title":"Left atrial appendage closure compared with oral anticoagulants for patients with atrial fibrillation: a systematic review and network meta-analysis.","volume":"13","author":"Oliva","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"R8-20250905","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.121.057063","article-title":"Amplatzer Amulet left atrial appendage occluder versus Watchman device for stroke prophylaxis (Amulet IDE): a randomized, controlled trial.","volume":"144","author":"Lakkireddy","year":"2021","journal-title":"Circulation"},{"key":"R9-20250905","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.jcin.2017.06.072","article-title":"Percutaneous left atrial appendage closure with the LAmbre device for stroke prevention in atrial fibrillation: a prospective, multicenter clinical study.","volume":"10","author":"Huang","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"R10-20250905","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jacc.2007.02.035","article-title":"Initial worldwide experience with the WATCHMAN Left Atrial Appendage System for stroke prevention in atrial fibrillation.","volume":"49","author":"Sick","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R11-20250905","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jacc.2011.11.028","article-title":"The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.","volume":"59","author":"Viles-Gonzalez","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R12-20250905","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2174\/1573403X13666170927122036","article-title":"Transseptal access to the left atrium: tips and tricks to keep it safe derived from single operator experience and review of the literature.","volume":"13","author":"Manolis","year":"2017","journal-title":"Curr Cardiol Rev"},{"key":"R13-20250905","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jcin.2019.08.054","article-title":"Expert recommendations on cardiac computed tomography for planning transcatheter left atrial appendage occlusion.","volume":"13","author":"Korsholm","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"R14-20250905","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.jcin.2023.06.007","article-title":"Left atrial appendage occlusion under miniaturized transesophageal echocardiographic guidance and conscious sedation: multicenter European experience.","volume":"16","author":"Aminian","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"R15-20250905","doi-asserted-by":"crossref","first-page":"943","DOI":"10.5114\/aoms.2012.32400","article-title":"Computed tomography for detecting left atrial thrombus: a meta-analysis.","volume":"8","author":"Wu","year":"2012","journal-title":"Arch Med Sci"},{"key":"R16-20250905","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4244\/EIJY19M08_01","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update.","volume":"15","author":"Glikson","year":"2020","journal-title":"EuroIntervention"},{"key":"R17-20250905","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/24748706.2019.1663381","article-title":"Incidence, characteristics and management of persistent peri-device flow after percutaneous left atrial appendage occlusion.","volume":"3","author":"Alkhouli","year":"2019","journal-title":"Struct Heart"},{"key":"R18-20250905","doi-asserted-by":"crossref","first-page":"e944","DOI":"10.4244\/EIJ-D-21-00320","article-title":"Prevalence","volume":"17","author":"Agudelo","year":"2021","journal-title":"EuroIntervention"},{"key":"R19-20250905","doi-asserted-by":"crossref","first-page":"euad237","DOI":"10.1093\/europace\/euad237","article-title":"Mechanisms, predictors, and evolution of severe peri-device leaks with two different left atrial appendage occluders.","volume":"25","author":"Lakkireddy","year":"2023","journal-title":"Europace"},{"key":"R20-20250905","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jacep.2021.06.018","article-title":"Temporal changes and clinical implications of delayed peridevice leak following left atrial appendage closure.","volume":"8","author":"Afzal","year":"2022","journal-title":"Clinical Electrophysiology"},{"key":"R21-20250905","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.4244\/EIJ-D-17-00469","article-title":"Residual leaks following percutaneous left atrial appendage occlusion: assessment and management implications.","volume":"13","author":"Raphael","year":"2017","journal-title":"EuroIntervention"},{"key":"R22-20250905","doi-asserted-by":"crossref","first-page":"e34185","DOI":"10.1097\/MD.0000000000034185","article-title":"Amplatzer Amulet versus Watchman device for percutaneous left atrial appendage closure: a systematic review and meta-analysis.","volume":"102","author":"Jaiswal","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"R23-20250905","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jacc.2024.10.101","article-title":"5-year results from the Amplatzer Amulet left atrial appendage occluder randomized controlled trial.","volume":"85","author":"Lakkireddy","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"R24-20250905","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/eurheartj\/ehad828","article-title":"Residual leaks following percutaneous left atrial appendage occlusion and outcomes: a meta-analysis.","volume":"45","author":"Samaras","year":"2024","journal-title":"Eur Heart J"},{"key":"R25-20250905","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1159\/000532019","article-title":"The effect of peri-device leaks on ischaemic stroke\/transient ischaemic attack\/systemic embolism after left atrial appendage closure: a systematic review and meta-analysis.","volume":"148","author":"He","year":"2023","journal-title":"Cardiology"},{"key":"R26-20250905","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.amjcard.2023.07.102","article-title":"Meta-analysis of the outcomes of peri-device leak after left atrial appendage closure.","volume":"204","author":"Mostafa","year":"2023","journal-title":"Am J Cardiol"},{"key":"R27-20250905","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jcin.2023.01.008","article-title":"Impact of computational modeling on transcatheter left atrial appendage closure efficiency and outcomes.","volume":"16","author":"De Backer","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"R28-20250905","doi-asserted-by":"crossref","first-page":"1088782","DOI":"10.3389\/fcvm.2022.1088782","article-title":"An updated meta-analysis of device related thrombus following left atrial appendage closure in patients with atrial fibrillation.","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R29-20250905","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jacep.2022.07.014","article-title":"Incidence, predictors, and clinical outcomes of device-related thrombus in the Amulet IDE trial.","volume":"9","author":"Schmidt","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"R30-20250905","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1016\/j.jcin.2023.10.046","article-title":"Device-related thrombus after left atrial appendage occlusion: clinical impact, predictors, classification, and management.","volume":"16","author":"Alkhouli","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"R31-20250905","doi-asserted-by":"crossref","first-page":"e2214594","DOI":"10.1001\/jamanetworkopen.2022.14594","article-title":"Periprocedural outcomes associated with use of a left atrial appendage occlusion device in China.","volume":"5","author":"Su","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R32-20250905","doi-asserted-by":"crossref","first-page":"e011718","DOI":"10.1161\/CIRCINTERVENTIONS.121.011718","article-title":"Periprocedural pericardial effusion complicating transcatheter left atrial appendage occlusion: a report from the NCDR LAAO Registry.","volume":"15","author":"Price","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"R33-20250905","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/pace.14576","article-title":"Safety and efficacy of the Amplatzer Amulet and Watchman 2.5 for left atrial appendage occlusion: a systematic review and meta\u2010analysis.","volume":"45","author":"Zhu","year":"2022","journal-title":"Pacing Clin Electrophysiol"},{"key":"R34-20250905","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1016\/j.jacep.2024.08.016","article-title":"Pulmonary artery injury following endocardial left atrial appendage occlusion: the known and unknown.","volume":"10","author":"Katapadi","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"R35-20250905","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.jcct.2021.11.002","article-title":"A case of pulmonary vein to left atrial appendage fistula after transcatheter left atrial appendage occlusion.","volume":"16","author":"Alyami","year":"2022","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"R36-20250905","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.hrthm.2023.01.007","article-title":"SCAI\/HRS expert consensus statement on transcatheter left atrial appendage closure.","volume":"20","author":"Saw","year":"2023","journal-title":"Heart Rhythm"},{"key":"R37-20250905","doi-asserted-by":"crossref","first-page":"1388024","DOI":"10.3389\/fcvm.2024.1388024","article-title":"Management of complications associated with percutaneous left atrial appendage closure with or without ablation: experience from 512 cases over a 4-year period.","volume":"11","author":"Zou","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"R38-20250905","doi-asserted-by":"crossref","first-page":"euae035","DOI":"10.1093\/europace\/euae035","article-title":"Practical guide on left atrial appendage closure for the non-implanting physician: an international consensus paper.","volume":"26","author":"Potpara","year":"2024","journal-title":"Europace"},{"key":"R39-20250905","first-page":"128","article-title":"Embolization of left atrial appendage closure devices: a systematic review of cases reported with the Watchman device and the Amplatzer cardiac plug.","volume":"86","author":"Aminian","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"R40-20250905","doi-asserted-by":"crossref","first-page":"e012812","DOI":"10.1161\/CIRCINTERVENTIONS.122.012812","article-title":"Antithrombotic management after left atrial appendage closure: current evidence and future perspectives.","volume":"16","author":"Mesnier","year":"2023","journal-title":"Circ Cardiovasc Interv"},{"key":"R41-20250905","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jacc.2022.02.047","article-title":"Antithrombotic therapy after left atrial appendage occlusion in patients with atrial fibrillation.","volume":"79","author":"Freeman","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R42-20250905","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/pace.15184","article-title":"A current perspective on left atrial appendage closure device infections: a systematic review.","volume":"48","author":"Sener","year":"2025","journal-title":"Pacing Clin Electrophysiol"},{"key":"R43-20250905","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s12016-021-08867-0","article-title":"Nickel hypersensitivity to atrial septal occluders: smoke without fire?","volume":"62","author":"Apostolos","year":"2022","journal-title":"Clin Rev Allergy Immunol"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000001035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T13:01:23Z","timestamp":1757077283000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000001035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":43,"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000001035","relation":{},"ISSN":["1538-4683"],"issn-type":[{"type":"electronic","value":"1538-4683"}],"subject":[],"published":{"date-parts":[[2025,9,5]]}}}